Treatment Tailored to Your Biology
Rose Higgins, chief executive officer at HealthMyne, Inc., sits down with Sam to discuss the role radiomics is playing in cancer care. Our biology-guided radiotherapy will generate a plethora of new data that will one day become part of the data fabric to help us understand what is happening at both the molecular and biological level. This podcast dives into how radiomics can provide insights to better inform treatment decisions and what the future may hold.
Chief Executive Officer, HealthMyne
Sam Mazin, PhD
Founder and CTO, RefleXion
735-00094 Rev A